// App-Quantinova.ai

PB1780 : Plasma Concentration of Activated Factor VII-antithrombin, But Not Tissue Factor Pathway Inhibitor and Factor VII Levels, Predicts Mortality in Subjects with Liver and Colon Cancer Undergoing Curative Surgical Intervention

Researchers

Presenter

  • D. De Santis

Principal Investigators

  • A. Castagna

  • S. Moruzzi

  • S. Udali

  • M. Baroni

  • P. Pattini

  • A. Ruzzenente

  • S. Conci

  • T. Campagnaro

  • B. Woodhams

  • P. Van Dreden

  • A. Guglielmi

  • F. Bernardi

  • O. Olivieri

  • S. Friso

  • N. Martinelli

Medical Centers

  • University of Verona, Pediatrics, Verona, Italy

  • University of Ferrara, Department of Life Sciences and Biotechnology, Ferrara, Italy

  • University of Verona, Verona, Italy

  • HaemaCon Ltd, Bromley, United Kingdom

  • Diagnostica Stago, Clinical Research, Gennevilliers, France

Locations

  • Italy

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Advanced biliary tract carcinoma

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • Coagulation Factor III, Tissue Factor

  • Tissue factor pathway inhibitor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved